ClinTex’s Clinical Trials Intelligence (CTi) is a decentralized enterprise solution designed to reduce the cost of medicine and speed up access to a new medicine for individuals who need it by minimizing development costs for the international pharmaceutical industry. It will achieve that by reinventing how clinical trials are done by using a combination of smart contracts on the Ethereum public blockchain and their private consortium blockchain. At its core, the platform is a decentralized database of clinical data, but will also host seven applications, the main function of which will be the optimization and management of the pain points of conducting clinical trials.
ClinTex is a data analytics platform that utilizes the advantages of distributed ledger technology. It leverages Ethereum public blockchain smart contracts to offer an end to end decentralized solution which incorporates tools to encourage collaboration in clinical trial data sharing across the sector and significant operational and quality improvements in conducting clinical trials through machine learning (AI), predictive data analytics, insightful operational key performance indicators (KPIs), and advanced clinical data review. The ClinTex CTi platform will drastically enhance pharmaceutical firms’ clinical and operational efficiency in overseeing, conducting, reviewing, setting-up, and satisfying regulatory standards for clinical trials.
The ClinTex CTi platform’s foundation lies simultaneously in the development of an ecosystem that allows interoperability of every clinical trial data view and, with the use of blockchain technology, the ability to provide a safe environment for the storage and analysis of certain historical clinical data views. In that way, the platform offers an optimum environment for sharing clinical data views and creating data analytics solutions while addressing stakeholders’ security and privacy concerns.
Through the CTi platform, an ecosystem is built with seven decentralized applications, which will offer valuable clinical insight using machine learning and predictive analytical tools for the benefit of Clinical Trial Physicians, Clinical Project Managers, Clinical Data Managers, Site Monitors, and Pharmacovigilance staff.
|Price||1 CLX = 0.1 USD|
|Soft Cap||4,000,000 USD|
|Hard Cap||19,000,000 USD|
|Whitelist/KYC||KYC & Whitelist|